| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site A from fifth wave H7N9-infected humans
|
Li, Mingxin
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 2 |
An endogenous retroviral element exerts an antiviral innate immune function via the derived lncRNA lnc-ALVE1-AS1
|
Chen, Shihao
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 3 |
Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro
|
Nishiyama, Takashi
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 4 |
Aurora kinase A promotes hepatitis B virus replication and expression
|
Jeong, Gi Uk
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 5 |
Cat flu: Broad spectrum polymeric antivirals
|
Synowiec, Aleksandra
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 6 |
CD4 recovery is associated with genetic variation in IFNγ and IL19 genes
|
García, Marcial
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 7 |
Differing activities of oxysterol-binding protein (OSBP) targeting anti-viral compounds
|
Roberts, Brett L.
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 8 |
Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis
|
McDaniel, Yumeng Z.
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 10 |
FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis
|
Qu, Changbo
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 11 |
FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α
|
Li, Lijie
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 12 |
Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine
|
Spengler, Jessica R.
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 13 |
High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics
|
Wendt, Lisa
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 14 |
Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus
|
Miller, Joanna L.
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 15 |
Intraperitoneal injection with dengue virus type 1-infected K562 cells results in complete fatality among immunocompetent mice
|
Yamanaka, Atsushi
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 16 |
Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment
|
Luo, Dan
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 17 |
New antibody-based prevention and treatment options for influenza
|
Sedeyn, Koen
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 18 |
NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions
|
Banerjee, N. Sanjib
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 19 |
Polyphenylene carboxymethylene (PPCM) in vitro antiviral efficacy against Ebola virus in the context of a sexually transmitted infection
|
Escaffre, Olivier
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 20 |
Publisher's Note
|
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 21 |
Rapid isolation of a potent human antibody against H7N9 influenza virus from an infected patient
|
Li, Junxin
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 22 |
Sofosbuvir susceptibility of genotype 1 to 6 HCV from DAA-naïve subjects
|
Han, Bin
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 23 |
Susceptibility of Enterovirus-D68 to RNAi-mediated antiviral knockdown
|
Klaiber, Nicholas
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 24 |
The Val430Ile neuraminidase (NA) substitution, identified in influenza B virus isolates, impacts the catalytic 116Arg residue causing reduced susceptibility to NA inhibitors
|
Abed, Yacine
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 25 |
T-705 induces lethal mutagenesis in Ebola and Marburg populations in macaques
|
Espy, Nicole
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 26 |
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
|
Eron, Joseph J.
|
|
2019
|
170 |
C |
p.
|
artikel
|
| 27 |
Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection
|
Zhang, Wei
|
|
2019
|
170 |
C |
p.
|
artikel
|
Tijdschrift beschrijving